The global cystatin C testing market was valued at around US$ 194.3 Mn at the end of 2021. The market is projected to register a 7.5% CAGR and top a valuation of US$ 400.4 Mn by 2032.
“Launch of various cystatin C testing kits and increasing prevalence of cystatin C-positive disorders among the population across the globe is expected to propel the cystatin C testing market growth.”
Attributes
Details
Cystatin C Testing Market Value in 2021
US$ 194.3 Mn
Cystatin C Testing Market Value in 2032
US$ 400.4 Mn
Cystatin C Testing Market CAGR (2022-2032)
7.5%
The quantity of a protein, cystatin C in the blood is measured by the cystatin C test. Cystatin C is constantly created by the human body, and the protein is detected in several fluids, including spinal fluid, breast milk, and blood. The healthy kidneys sieve cystatin C from the blood so that it can be defecated in the urine.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
What are the Major Drivers Boosting the Demand for Cystatin C Testing Market?
The increasing prevalence of several disorders such as myocardial infarction, and muscular dystrophy is one of the major factors that is accelerating the market growth. Besides this, the favorable reimbursement policies in the healthcare sector are a great advantage for cystatin C testing.
Furthermore, the growth in the number of pathology laboratories, hospital laboratories, research labs, and diagnostic centers across the geographies is boosting the market growth for the cystatin C testing market. Apart from this, the low cost of the reagents is also one of the major market stimulating factors. The increased investments in the healthcare sector by the government organizations of several nations are also expected to favor the cystatin C testing market.
Moreover, the major businesses in the market are highly investing in research and development activities, to offer novel and high-quality testing kits and products to the end users such as diagnostic laboratories, clinics, and hospitals. Besides this, the key market players are concentrating on activities like mergers and acquisitions. Due to these activities, the market is expected to grow at a rapid pace in the near future.
Which Region Shows Strong Growth Potential in the Cystatin C Testing Market?
North America held the largest share in the global cystatin C testing market and is expected to continue in the near future. The growing healthcare sector and the launch of novel products in the region are expected to accelerate the market during the forecast period. Europe is also estimated to witness lucrative growth over the projected period, owing to the advanced and developed healthcare facilities.
The increasing disposable income along with the rising health awareness, and increasing demand for diagnostic procedures especially in the geriatric population is the major factor that is expected to fuel the market growth in Asia Pacific Region.
Find your sweet spots for generating winning opportunities in this market.
Who are the Key Manufacturers in the Cystatin C Testing Market?
Some of the key manufacturers operating in the cystatin C testing market are Abbott, Eurolyser Diagnostica, Randox Laboratories, DiaSys Diagnostic Systems, Diazyme Laboratories, Tosoh India Pvt. Ltd., BBI Solutions, PerkinElmer, Siemens Healthcare Private Limited, and Pointe Scientific Inc.
Scope of Report
Report Attributes
Details
Growth Rate
CAGR of 7.5% 2022-2032
Base Year for Estimation
2021
Historical Data
2012-2021
Forecast Period
2022-2032
Qualitative Units
Revenue in USD Billion and CAGR from 2022-2032
Report Coverage
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segment Covered
Product
Test
Application
End User
Region
Region Covered
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa
Key Countries Profiled
U.S
Canada
Brazil
Mexico
Germany
U.K
France
Spain
Italy
China
Japan
South Korea
Malaysia
Singapore
Australia
New Zealand
GCC
South Africa
Israel
Key Players
Abbott
Eurolyser Diagnostica
Randox Laboratories
DiaSys Diagnostic Systems
Diazyme Laboratories
Tosoh India Pvt. Ltd.
BBI Solutions
PerkinElmer
Siemens Healthcare Private Limited
Pointe Scientific Inc.
Customization
Available Upon Request
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Key Segments Covered in the Cystatin C Testing Industry Survey
By Product:
Instruments
Regents
Kits
By Test:
Colorimetric Assay Based Tests
Enzymatic Tests
Point of Care Tests
ELISA Based Tests
Others
By Application:
Research and Development
Diagnosis Use
By End User:
Hospitals
Clinics
Diagnostic Laboratories
Renal Care Centers
Academic Research Institutes
By Region:
North America
Latin America
Europe
East Asia
South Asia & Pacific
The Middle East and Africa (MEA)
Frequently Asked Questions
The global cystatin C testing market is anticipated to register a CAGR of 7.5% during the forecast period.
Abbott, Eurolyser Diagnostica, Randox Laboratories, DiaSys Diagnostic Systems, Diazyme Laboratories, Tosoh India Pvt. Ltd., BBI Solutions, PerkinElmer, Siemens Healthcare Private Limited, and Pointe Scientific Inc. among others are some prominent cystatin C testing market players.
- Request for Table of Contents -
Complete the form below and we'll get back to you shortly
